 |
2009 Abstracts
- Burashnikov E, Pfeiffer R, Borggrefe M, Eldar M, Glikson G, Haissaguerre M, Kanter R, Laino R, Marieb M, Nadmanee K, Nam GB, Robles R, Schimpf R, Stapleton D, Viskin S, Winters S, Wolpert C, Zimmern S, Antzelevitch C. Mutations in the cardiac L-type calcium channel associated with four sudden cardiac death syndromes. Circulation. 2009;120:S573. Abstract 1929.
- Burashnikov A, Di Diego JM, Linhardt G, Carlsson L, Antzelevitch,C. AZD1305 has atrial-predominant electrophysiologic actions and is effective in suppressing atrial fibrillation in the dog. Heart Rhythm. 2009;6:685.
- Sicouri S, Talarico M, Antzelevitch C. Antiarrhythmic effects of losartan and enalapril in canine pulmonary vein sleeves. Heart Rhythm. 2009;6(5S):S91. Abstract AB42-4.
- Burashnikov A, Barajas-Martinez H, Hu D, Nof E, Blazek J, Antzelevitch C. The atrial-selective potassium channel blocker AVE0118 prolongs effective refractory period in canine atria by inhibiting sodium channels. Heart Rhythm. 2009;6(5S):S98. Abstract PO01-11.
- Nof E, Belhassen B, Arad M, Bhuiyan ZA, Antzelevitch C, Rosso R, Fogelman R, Luria D, Eli-Ani D, Viskin S, Eldar M, A.M Wilde AAM, Glikson M. Post pacing abnormal repolarization in a CPVT family associated with a RYR2 mutation. Heart Rhythm. 2009;6(5S):S101-S102. Abstract PO01-20.
- Veltmann C, Schimpf R, Kuschyk J, Streitner F, Pfeiffer R, Hu D, Borggrefe M, Wolpert C, Antzelevitch C. Outcome and follow-up of a family with a highly malignant SCN5A mutation. Heart Rhythm. 2009:6(5S):S179-S180. Abstract PO02-112.
- Hu D, Barajas-Martinez H, Burashnikov E, Springer M, Wu Y, Pfeiffer R, Guerchicoff A, Pollevick GD, Antzelevitch C. A mutation in the ß3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Heart Rhythm. 2009;6(5S):S204-S205. Abstract PO03-6.
- Nof E, Laish-Farkash A, Marek D, Pras E, Eldar M, Antzelevitch C, Glikson M, Luria D. Triple mutation of SCN5A associated with sinus bradycardia and conduction disease. Heart Rhythm. 2009;6(5S):S205. Abstract PO03-7.
- Kapplinger JD, Wilde AAM, Antzelevitch C, Benito B, Berthet M, Brugada J, Brugada P, Fressart V, Guerchicoff A, Guicheney P, Kamakura S, Koopmann TT, Miyamoto M, Pollevick GD, Pfeiffer R, Probst V, Salisbury BA, Schulze-Bahr E, Shimizu W, Towbin JA, Vatta M, Zumhagen S, Schott J, Brugada R, Ackerman MJ. A worldwide compendium of putative Brugada syndrome associated mutations in the SCN5A encoded cardiac sodium channel. Heart Rhythm. 2009;6(5S):S392-S393. Abstract PO06-6.
- Jons C, Sogaard P, Johannesen A, Hansen TF, Antzelevitch C, Bloch Thomsen PE. Conduction impairment and reduced contractility are prerequisites for RVOT ectopy. Heart Rhythm. 2009;6(5S):S427. Abstract PO06-101.
- Veltmann V, Schimpf R, Streitner F, Kuschyk J, Pfeiffer R, Borggrefe M, Hu D, Wolpert C, Antzelevitch C. Phenotypic characterization of a large European family with overlapping syndromes due to an SCN5A mutation. Heart Rhythm. 2009;6(5S):S432. Abstract PO06-114.
- Zygmunt AC, Nesterenko VV, Rajamani S, Hu D, Barajas-Martínez H, Belardinelli L, Antzelevitch C. Mechanism of the preferential block of the atrial sodium current by ranolazine. Biophys J. 2009;96(3s):250a. Abstract 1278-Pos.
- Barajas-Martínez H, Hu D, Ontiveros G, Caceres G, Burashnikov E, Scaglione J, Antzelevitch C. Biophysical characterization of a novel KCNJ2 mutation associated with Andersen-Tawil syndrome and CPVT mimicry. Biophys J. 2009;96(3s):260a. Abstract 1333-Pos.
- Hu D, Barajas-Martínez H, Pfeiffer R, Guerchicoff A, Cordeiro JM, Curtis AB, Pollevick GD, Wu Y, Burashnikov E, Antzelevitch C. Dual variations in SCN5A and CACNB2b underlie cardiac conduction disease without Brugada syndrome. Biophys J. 2009;96(3s):261a. Abstract 1335-Pos.
- Calloe K, Jespersen T, Lundby A, Antzelevitch C, Olesen SP, Cordeiro JM. Differential effects of the transient outward K+ current activator NS5806 in the canine left ventricle. Biophys J. 2009;96(3s):659a. Abstract 3401-Pos.
- Lundby A, Jespersen T, Schmitt N, Grunnet M, Olesen SP, Cordeiro JM, Calloe K. The effect of the Ito activator NS5806 on cloned Kv4.3 channels is dependent on the accessory protein KChIP2. Biophys J. 2009;96(3s):659a. Abstract 3402-Pos.
- Calloe K, Cordeiro JM, Di Diego JM, Hansen RS, Grunnet M, Olesen SP, Antzelevitch C. NS5806 activates the transient outward potassium current in the canine ventricle and provides a new model of the Brugada syndrome. Biophys J. 2009;96(3s):666a. Abstract 3438-Pos.
|
